Chrysin ameliorates hepatic steatosis induced by a diet deficient in methionine and choline by inducing the secretion of hepatocyte nuclear factor 4α-dependent very low-density lipoprotein

Chrysin ameliorates nonalcoholic fatty liver disease in rats

(2019) Sarayu A. Pai et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Chrysin: Pharmacological and therapeutic properties

(2019) Saima Naz et al.   LIFE SCIENCES

Chrysin ameliorates cerebral ischemia/reperfusion (I/R) injury in rats by regulating the PI3K/Akt/mTOR pathway

(2019) Teng-Fei Li et al.   NEUROCHEMISTRY INTERNATIONAL

Chrysin attenuates inflammatory and metabolic disorder indices in aged male rat

(2018) Tahereh Farkhondeh et al.   BIOMEDICINE & PHARMACOTHERAPY

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

(2016) Elena Buzzetti et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Quantitative succinylome analysis in the liver of non-alcoholic fatty liver disease rat model

(2016) Yang Cheng et al.   Proteome Science

Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009

(2015) Zobair M. Younossi et al.   HEPATOLOGY

The Role of Oral Antidiabetic Agents and Incretin Mimetics in Type 2 Diabetic Patients with Non-Alcoholic Fatty Liver Disease

(2014) Ioanna Gouni-Berthold et al.   CURRENT PHARMACEUTICAL DESIGN

Diabetes and Nonalcoholic Fatty Liver Disease: A Pathogenic Duo

(2013) K. H. Williams et al.   ENDOCRINE REVIEWS

Extrahepatic complications of nonalcoholic fatty liver disease

(2013) Matthew J. Armstrong et al.   HEPATOLOGY

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

(2013) Quentin M. Anstee et al.   Nature Reviews Gastroenterology & Hepatology

Non-alcoholic fatty liver disease

(2011) Briohny W. Smith et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis

(2011) Anabela P. Rolo et al.   FREE RADICAL BIOLOGY AND MEDICINE

Human Fatty Liver Disease: Old Questions and New Insights

(2011) J. C. Cohen et al.   SCIENCE

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010)   NEW ENGLAND JOURNAL OF MEDICINE